Recent noteworthy reports on diffuse large B-cell lymphoma (DLBCL) include positive survival results with an antibody-drug ...

In vivo CD19 CAR T-cell therapy showed promising results in a feasibility study of five patients with refractory systemic ...

Researchers have identified how to encourage tumors to build their own immune hubs—structures that look and function like ...

Scientists at Montefiore Einstein Comprehensive Cancer Center (MECCC) and Albert Einstein College of Medicine have shown for ...

DuoCAR20.19.22-D95 targets CD19, CD20, and CD22, addressing antigen escape in B-cell malignancies like B-ALL and B-NHL. Early ...

Post-CAR T infection prophylaxis should follow European Hematology Association/European Society for Blood and Marrow ...

CD19-targeting UB-VV11 became the first in vivo CAR-T cell therapy to be cleared for human testing by the FDA last year, and ...

An innovative approach could transform the treatment landscape for DLBCL patients, offering hope to those who might otherwise ...

In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children’s ...

In experiments with mouse models of breast, pancreatic, and muscle cancers, researchers at Johns Hopkins All Children's Hospital report new evidence that a novel means of boosting the natural immune ...

The New Brunswick government is partnering with Bell Canada to install 10 new cellular towers to improve rural cell service.

Maharashtra B.Pharmacy CAP Round-I Result 2025 will be released today, October 3, at ph2025.mahacet.org. Check allotment, cut ...